Health Care Costs
Shorter course of higher dose radiation therapy provide effective treatment, costs less, and is easier on patients than current standard radiation therapy course.
Although 75 percent of provider organizations can offer estimate, less than 25 percent of patients request one.
Researchers found that non-elderly cancer survivors may be particularly vulnerable to financial toxicity.
Researchers sought to conduct a cost-effectiveness analysis of immunotherapy for patients with advanced melanoma.
Researchers estimate that from 2016 to 2025, national health expenditures will grow at an annual rate of 5.6 percent yearly.
The Patient Care Connect Program lowers Medicare costs and provides other benefits, research indicates.
First-in-class drugs are fast-tracked while follow-on drugs can take up to 15 years to be approved by the FDA.
In his plenary lecture at 2016 SABCS, Peter P. Bach, MD, MAPP, reviewed the factors contributing to escalating drug prices and the significance of drug prices in the value of a cancer treatment regimen.
For patients with head and neck or lung cancer, stepped care programs may offer a more affordable yet effective approach.
A study presented at SABCS 2016 reports on the incidence of complications and costs in women who undergo breast-conserving surgery for breast carcinoma.
More Americans are experiencing relief with medical bills, but there is still room for improvement.
Economic Burden Related to Chemotherapy-related Adverse Events in Patients with Metastatic Breast Cancer in an Integrated Health Care SystemNovember 04, 2016
[Breast Cancer: Targets and Therapy] This research evaluates costs related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care delivery system.
A recent study examined the current economic burden attributable to vaccine-preventable diseases among U.S. adults.
There is a lot of talk about biosimilar drugs. What makes a drug a biosimilar?
Researchers found wide variances in the cost of breast cancer chemotherapy, depending on the course of treatment selected.
Patients with cancer incur significant out-of-pocket costs before their Medicare drug benefits activate, and due to those costs, many patients with CML delayed starting their treatment.
Patient abuse of opioids costs the U.S. economy $78.5 billion a year, including the costs of health care, lost productivity, and treatment programs.
Researchers from the University of Miami School of Business Administration and the Florida Atlantic University College of Business present an overview of the impact of the ACA on US health care in its first 5 years.
Ambulatory bloodstream infections in pediatric oncology and stem cell transplant patients result in significant health care charges and extended hospital admissions.
Improvement seen in all age levels, but millions still struggle with the cost of prescription drugs
Younger cancer survivors in Norway were more likely to be financially dependent and unemployed than individuals without cancer.
Number of Medicare beneficiaries getting compounded drugs up 281 percent since 2006
More transparency regarding the costs of various treatment regimens in real time is needed to "choose wisely" for patients, providers, and payers.
Readmission Rates at Hospitals After Cancer-Related Procedures Is Too Complex for Simple Reimbursement RulesJune 17, 2016
Rates of readmission to hospitals after complex cancer surgeries are usually higher in vulnerable hospitals that serve as safety nets in their communities or in hospitals with a large number of Medicaid-insured patients.
What are the practical considerations for implementing a lung cancer screening program in a health care system? This question was addressed by Abbie Begnaud, MD, assistant professor, pulmonary, critical care, University of Minnesota, in a presentation at the 2016 ASCO Annual Meeting.
A month of treatment with the newest cancer drugs, based on those introduced in 2014, was 6 times more expensive at launch than cancer drugs introduced in 2000, after adjusting for inflation.
Access to specialty drugs is significantly reduced when insurers require patients to share the high costs of these drugs. Specialty drugs are often the only chance for patients with cancer to achieve long-term survival.
Offering free pap smears for cervical cancer screening did not increase pap smear frequency in low income women, even though low income and socioeconomic status are more likely to predict women skipping pap smears.
With the January 2016 expiration of the patent on Gleevac, significant cost savings can be realized by insurance companies and patients. Just 15 years ago, Gleevac (imatinib) changed chronic myeloid leukemia (CML) from a fatal disease to a treatable illness.
The Samfund is a not-for-profit organization dedicated to easing the lasting financial effects of cancer treatments for young adults with the disease.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|